| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Troy A. Ignelzi | Chief Financial Officer | $20M | Aug 22, 2023 | ||
| Charmaine Lykins | Chief Commercial Officer | $8.29M | Nov 29, 2021 | ||
| Heather Preston | Director | $3.02M | Jun 24, 2021 | ||
| Jeffrey M. Jonas | Director | $0 | Mar 15, 2024 | ||
| Coughlin Christopher J | Director | $0 | Mar 18, 2024 | ||
| Steven M. Paul | Director | $0 | Mar 18, 2024 | ||
| Denice Torres | Director | $0 | Mar 18, 2024 | ||
| James Healy | Director | $0 | Mar 18, 2024 | ||
| William Meury | President and CEO, Director | $0 | Mar 18, 2024 | ||
| Laurie J. Olson | Director | $0 | Mar 18, 2024 | ||
| Stephen K. Brannan | Chief Medical Officer | $0 | Mar 18, 2024 | ||
| Jason Brown | Chief Financial Officer | $0 | Mar 18, 2024 | ||
| Atul Pande | Director | $0 | Mar 18, 2024 | ||
| David E. Wheadon | Director | $0 | Mar 18, 2024 | ||
| William P. Kane Jr | Chief Commercial Officer | $0 | Mar 18, 2024 | ||
| Andrew Craig Miller | President of R&D | $0 | Mar 18, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|